Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$0.65 - $1.1 $50,480 - $85,429
77,663 New
77,663 $63.7 Million
Q4 2022

Feb 14, 2023

BUY
$0.48 - $0.88 $37,278 - $68,343
77,663 New
77,663 $51,000
Q2 2022

Aug 15, 2022

SELL
$0.8 - $1.5 $139,146 - $260,899
-173,933 Reduced 69.02%
78,055 $66,000
Q1 2022

May 11, 2022

BUY
$1.24 - $2.75 $9,724 - $21,565
7,842 Added 3.21%
251,988 $343,000
Q4 2021

Feb 11, 2022

BUY
$2.42 - $3.65 $9,229 - $13,921
3,814 Added 1.59%
244,146 $610,000
Q3 2021

Nov 12, 2021

BUY
$2.82 - $3.7 $40,543 - $53,194
14,377 Added 6.36%
240,332 $774,000
Q2 2021

Aug 11, 2021

SELL
$3.5 - $5.48 $13,030 - $20,402
-3,723 Reduced 1.62%
225,955 $806,000
Q1 2021

May 13, 2021

SELL
$3.16 - $4.89 $74,879 - $115,873
-23,696 Reduced 9.35%
229,678 $810,000
Q4 2020

Feb 09, 2021

BUY
$2.2 - $4.45 $76,837 - $155,420
34,926 Added 15.99%
253,374 $803,000
Q3 2020

Nov 12, 2020

BUY
$2.62 - $4.78 $23,325 - $42,556
8,903 Added 4.25%
218,448 $882,000
Q2 2020

Aug 12, 2020

BUY
$1.83 - $3.16 $236,177 - $407,826
129,059 Added 160.35%
209,545 $561,000
Q1 2020

May 06, 2020

SELL
$1.14 - $2.96 $1,047 - $2,720
-919 Reduced 1.13%
80,486 $152,000
Q4 2019

Feb 14, 2020

BUY
$1.25 - $2.57 $55,988 - $115,112
44,791 Added 122.33%
81,405 $209,000
Q3 2019

Nov 07, 2019

SELL
$1.26 - $1.96 $34,275 - $53,317
-27,203 Reduced 42.63%
36,614 $51,000
Q2 2019

Aug 12, 2019

SELL
$1.43 - $1.94 $39,651 - $53,792
-27,728 Reduced 30.29%
63,817 $96,000
Q1 2019

May 14, 2019

SELL
$0.94 - $2.47 $422 - $1,109
-449 Reduced 0.49%
91,545 $163,000
Q2 2018

Aug 06, 2018

SELL
$2.92 - $5.1 $22,492 - $39,285
-7,703 Reduced 7.73%
91,994 $274,000
Q1 2018

May 15, 2018

SELL
$3.42 - $5.35 $25,691 - $40,189
-7,512 Reduced 7.01%
99,697 $454,000
Q4 2017

Feb 09, 2018

BUY
$3.26 - $4.84 $349,501 - $518,891
107,209
107,209 $428,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $194M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.